Market revenue in 2023 | USD 532.1 million |
Market revenue in 2030 | USD 1,512.9 million |
Growth rate | 16.1% (CAGR from 2023 to 2030) |
Largest segment | Tavr (transcatheter aortic valve replacement) |
Fastest growing segment | LAAC (Left Atrial Appendage Closure) |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | SAVR (Surgical Aortic Valve Replacement), TAVR (Transcatheter Aortic Valve Replacement), Mitral Repair (Annuloplasty), LAAC (Left Atrial Appendage Closure) |
Key market players worldwide | Boston Scientific Corp, Medtronic PLC, Edwards Lifesciences Corp, Abbott Laboratories, St. Jude Medical, LivaNova PLC, Stryker Corp, Lepu Medical, Biomerics, CardioKinetix |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to structural heart devices market will help companies and investors design strategic landscapes.
Tavr (transcatheter aortic valve replacement) was the largest segment with a revenue share of 54.2% in 2023. Horizon Databook has segmented the China structural heart devices market based on savr (surgical aortic valve replacement), tavr (transcatheter aortic valve replacement), mitral repair (annuloplasty), laac (left atrial appendage closure) covering the revenue growth of each sub-segment from 2018 to 2030.
The dynamic growth of China's structural heart devices market finds its roots in the profound shifts brought about by rapid urbanization and evolving lifestyle patterns. As urbanization accelerates, lifestyle changes have ushered in an era of heightened risk factors such as unhealthy dietary habits and sedentary lifestyles, magnifying the demand for structural heart devices.
Furthermore, the robust growth of the market is underpinned by substantial investments in healthcare infrastructure and R&D endeavors. These investments create an enabling environment for the adoption of cutting-edge technologies, notably transcatheter procedures like TAVR and TMVR, which are gaining prominence within China's healthcare landscape.
Horizon Databook provides a detailed overview of country-level data and insights on the China structural heart devices market , including forecasts for subscribers. This country databook contains high-level insights into China structural heart devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account